Drug profile · INN
mycophenolate mofetil hydrochloride
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
mycophenolate mofetil hydrochloride (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) is a inosine-5'-monophosphate dehydrogenase (impdh) inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — mycophenolate mofetil hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
mycophenolate mofetil hydrochloride (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) is a inosine-5'-monophosphate dehydrogenase (impdh) inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
Primary target: Inosine-5'-monophosphate dehydrogenase (IMPDH)
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is mycophenolate mofetil hydrochloride?
mycophenolate mofetil hydrochloride (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) is a inosine-5'-monophosphate dehydrogenase (impdh) inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for mycophenolate mofetil hydrochloride?
MYCOPHENOLATE MOFETIL HYDROCHLORIDE is a marketed brand name for mycophenolate mofetil hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mycophenolate mofetil hydrochloride?
mycophenolate mofetil hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.